Literature DB >> 21637021

Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection.

Tomohiro Watanabe1, Naoki Asano, Atsushi Kitani, Ivan J Fuss, Tsutomu Chiba, Warren Strober.   

Abstract

Infection of gastric epithelial cells with Helicobacter pylori (H. pylori) induces a complex array of host protective immune responses. The best known are the adaptive T helper type 1 and type 17 responses that are induced in the gastric lamina propria by antigen-presenting cells via presentation of H. pylori antigens to CD4(+) T cells. Recently, it has become apparent that innate immune responses are also induced by H.pylori infection, both in epithelial cells and in underlying antigen-presenting cells. One important component of these innate responses involves the activity of NOD1, an intra-cellular sensor of peptides derived from the peptidoglycan component of the bacterial cell wall. In this review, we discuss our recent work showing that the signaling pathway utilized by NOD1 results in the generation of type I interferon and that this cytokine mediates both chemokine and cytokine responses that regulate the severity of gastric H. pylori infection.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637021      PMCID: PMC3225799          DOI: 10.4161/gmic.2.1.15162

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  30 in total

1.  The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection.

Authors:  T Itoh; Y Wakatsuki; M Yoshida; T Usui; Y Matsunaga; S Kaneko; T Chiba; T Kita
Journal:  J Gastroenterol       Date:  1999-10       Impact factor: 7.527

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.

Authors:  N Sawai; M Kita; T Kodama; T Tanahashi; Y Yamaoka; Y Tagawa; Y Iwakura; J Imanishi
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

6.  NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila.

Authors:  William R Berrington; Ravi Iyer; Richard D Wells; Kelly D Smith; Shawn J Skerrett; Thomas R Hawn
Journal:  Eur J Immunol       Date:  2010-11-11       Impact factor: 5.532

7.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island.

Authors:  Jérôme Viala; Catherine Chaput; Ivo G Boneca; Ana Cardona; Stephen E Girardin; Anthony P Moran; Rafika Athman; Sylvie Mémet; Michel R Huerre; Anthony J Coyle; Peter S DiStefano; Philippe J Sansonetti; Agnès Labigne; John Bertin; Dana J Philpott; Richard L Ferrero
Journal:  Nat Immunol       Date:  2004-10-17       Impact factor: 25.606

8.  Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors.

Authors:  Jae Gyu Kim; Sung Joong Lee; Martin F Kagnoff
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 9.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

10.  Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells.

Authors:  Tadakazu Hisamatsu; Manabu Suzuki; Daniel K Podolsky
Journal:  J Biol Chem       Date:  2003-06-17       Impact factor: 5.157

View more
  12 in total

1.  Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.

Authors:  Yi-Hsin Fan; Sujayita Roy; Rupkatha Mukhopadhyay; Arun Kapoor; Priya Duggal; Genevieve L Wojcik; Robert F Pass; Ravit Arav-Boger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

Review 2.  NLRP12 in innate immunity and inflammation.

Authors:  Shraddha Tuladhar; Thirumala-Devi Kanneganti
Journal:  Mol Aspects Med       Date:  2020-08-22

Review 3.  Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.

Authors:  Sheryl Coutermarsh-Ott; Kristin Eden; Irving Coy Allen
Journal:  J Gen Virol       Date:  2016-01-13       Impact factor: 3.891

4.  NOD1 and NOD2 Signaling in Infection and Inflammation.

Authors:  Lilian O Moreira; Dario S Zamboni
Journal:  Front Immunol       Date:  2012-11-08       Impact factor: 7.561

5.  Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.

Authors:  Arun Kapoor; Michael Forman; Ravit Arav-Boger
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

6.  Analysis of lncRNA, miRNA, and mRNA Expression Profiling in Type I IFN and Type II IFN Overexpressed in Porcine Alveolar Macrophages.

Authors:  Congcong Li; Haoyuan Han; Xiuling Li; Jiao Wu; Xinfeng Li; Hui Niu; Wantao Li
Journal:  Int J Genomics       Date:  2021-06-16       Impact factor: 2.326

Review 7.  Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses.

Authors:  Vivekanandhan Aravindhan; Haridoss Madhumitha
Journal:  J Diabetes Res       Date:  2016-08-16       Impact factor: 4.011

8.  Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway.

Authors:  Arun Kapoor; Yi-Hsin Fan; Ravit Arav-Boger
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

Review 9.  Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders.

Authors:  Tomohiro Watanabe; Naoki Asano; Masatoshi Kudo; Warren Strober
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 10.  Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Ken Kamata; Naoki Asano; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.